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The widespread occurrence of noncoding (nc) RNAs—unannotated eukaryotic transcripts 
with reduced protein coding potential—suggests that they are functionally important. Study 
of ncRNAs is increasing our understanding of the organization and regulation of genomes.Over the past five years, research-
ers working with various organisms 
and using multiple technologies to 
explore genomewide gene expres-
sion have converged on the same 
surprising conclusion: transcription is 
widespread throughout the genome 
and many-fold higher than existing 
genome annotations would predict. 
The burgeoning number of these 
transcripts of unknown function, or 
TUFs (Cheng et al., 2005), highlights 
a remarkably complex transcriptional 
architecture that includes alternative 
splice isoforms for almost all protein-
coding genes, widespread transcrip-
tion of antisense RNAs, and abun-
dant noncoding RNAs (ncRNAs) 
with important biological functions. 
By some estimates, TUFs could rival 
protein-coding transcripts in number 
(Cawley et al., 2004). Such transcrip-
tional diversity may explain how the 
relatively similar numbers of protein-
coding genes estimated for fruit fly 
(13,985; BDGP release 4), nematode 
worm (21,009; Wormbase release 
150), and human (23,341; NCBI 
release 36) result in the remarkable 
phenotypic differences observed 
among these species.
Widespread Transcription
Although recent evidence indicates 
that the complexity of transcripts 
produced by the human genome and 
the underlying transcriptional archi-
tecture is striking, these observa-
tions are consistent with much earlier 
reports. Decades ago, several studies 
discovered evidence for widespread 
transcription (see Table S1 available 
with this article online). In the 1970s, 
studies involving sea urchin embryos 
found that heterogeneous nuclear RNA had 10-fold more nucleotide 
complexity than cytoplasmic mRNA 
associated with polysomes. Studies 
of lampbrush chromosomes in newt 
oocytes estimated that empirically 
measured transcription was an order 
of magnitude greater than necessary 
to produce mRNAs for the oocyte. 
An abundance of nonpolyadenylated 
polysome-associated RNAs (?30% 
of cytoplasmic RNAs) was first iden-
tified in HeLa cells and subsequently 
observed in a variety of plant and 
animal cells. Furthermore, a 10-fold 
greater complexity of nuclear versus 
cytoplasmic polyadenylated (polyA) 
RNA was also found in human cells, 
and 5′ cap structures outnumber 
polyA segments 3:1 in hamster ovary 
cells. These original studies arrived at 
the common conclusion that the com-
plexity of transcripts made by most 
organisms seemed to be inexplicably 
larger than expected. Further insight 
into the nature of this transcriptional 
diversity awaited advancements in 
our understanding of primary struc-
ture of genomes and development of 
new analytical technologies.
Genomic tiling arrays represent an 
unbiased and sensitive tool for global 
studies of transcription. Such a tech-
nology offers independence from 
current limited genome annotations 
while enabling detection of rare tran-
scripts. Using genome tiling micro-
arrays, widespread transcription 
along chromosomes and across the 
human genome has been observed, 
including significant antisense prod-
ucts, and may be an order of magni-
tude greater than annotation-based 
predictions (reviewed in Johnson 
et al., 2005). In 2002, in a system-
atic analysis of transcription across Cell 125, Jhuman chromosomes 21 and 22, 
our group observed about an order 
of magnitude more transcriptional 
activity than could be accounted 
for by predicted protein-coding 
genes, suggesting that a significant 
portion of transcribed cytoplasmic 
polyA RNA may indeed be noncod-
ing. A subsequent human genome-
wide mapping effort of polyA RNA 
from human liver reached similar 
conclusions and identified >10,000 
new transcripts, many of which have 
homology to genomic sequences 
in other mammalian species. Tiling 
array-based whole-genome map-
ping in the model plant Arabidop-
sis found that >50% of observed 
transcription was intergenic and 
that ?30% of annotated genes had 
associated antisense transcription, 
some of which was tissue-specific. 
Furthermore, about 20% of anno-
tated pseudogenes were expressed, 
suggesting that examples of pseu-
dogene-mediated regulation of gene 
activity may be common (Hirotsune 
et al., 2003). In Drosophila, ?40% 
of probes in intronic and intergenic 
areas detected RNA expression, 
much of which changed in a devel-
opmentally coordinated manner. 
Furthermore, alternative splicing was 
observed in ?40% of known genes, 
yielding over 5000 new splice forms. 
Recently, even the small, well-char-
acterized yeast genome has yielded 
a more complex transcriptome than 
expected, with overlapping transcrip-
tion and differential expression levels 
even within the same gene (David et 
al., 2006). Together, these studies 
provide several observations about 
transcriptomes: (1) the widespread 
incidence of unannotated transcripts une 30, 2006 ©2006 Elsevier Inc. 1215
with limited protein-coding capac-
ity, often expressed at low levels; 
(2) a large degree of overlapping 
transcription, evidenced in part by 
the presence of abundant antisense 
transcription; and (3) most coding 
genes have alternative splice forms.
Combining chromatin immu-
noprecipitation (ChIP) and tiling 
microarrays has allowed unbiased, 
often high-resolution mapping of 
transcription factor binding sites 
across the genome, and in the pro-
cess has lent considerable unbiased 
empirical support to the existence of 
widespread unannotated transcrip-
tion. The binding sites of the NF-
κB family member RelA/p65 were 
mapped across human chromosome 
22, with nearly 28% of the binding 
sites shown to lie >50 kb away from 
known protein-coding genes (Mar-
tone et al., 2003). Mapping of DNA 
binding sites for Sp1, cMyc, and 
p53 transcription factors on human 
chromosomes 21 and 22 revealed 
that almost half of the mapped bind-
ing sites potentially correlate with 
ncRNAs, and a significant subset of 
the noncoding transcripts showed 
transcriptional responsiveness to 
retinoic acid (Cawley et al., 2004). 
Recently, a whole-genome map of 
RNA polymerase II preinitiation com-
plex binding sites in human primary 
fibroblasts identified ?10,000 active 
promoters, with approximately 13% 
corresponding to unannotated loci 
(Kim et al., 2005). Several factors 
could account for the substantially 
lower percent of observed binding 
sites that may correlate with non-
coding transcription, such as the 
highly conservative thresholds used 
to identify binding sites and the low 
occupancy by RNA polymerase for 
low abundance transcripts. Taken 
together, these results suggest that 
widespread transcription of TUFs is 
initiated and regulated by molecular 
mechanisms similar to those modu-
lating protein-coding RNAs.
Widespread unannotated tran-
scription has been confirmed by 
other experimental means, including 
mapping 5′ ends of transcripts using 
cap analysis of gene expression 
(CAGE), 3′ ends with serial analysis 1216 Cell 125, June 30, 2006 ©2006 Elsof gene expression (SAGE), mas-
sively parallel signature sequencing 
(MPSS), and high-throughput full-
length cDNA cloning and sequenc-
ing methodologies (reviewed in 
Mattick and Makunin, 2006). These 
sequencing-based approaches 
provide strand specificity for tran-
scripts and can detect transcripts 
originating from repetitive regions 
of the genome, whereas tiling 
arrays often have repetitive regions 
excluded and may use labeling pro-
tocols that are strand-insensitive. 
Expression analysis by SAGE tags 
found at least 15,000 uncharacter-
ized 3′ termini used in the genome, 
suggesting that new isoforms and 
genes numbered in the many thou-
sands. In the functional annotation 
of the mouse genome (FANTOM) 
project, large-scale sequencing 
and manual annotation of full-length 
cDNAs characterized 102,281 tran-
scripts, including 32,129 protein-
coding transcripts (2222 of which 
encode new proteins) and 34,030 
ncRNAs (Carninci et al., 2005). This 
study also concluded that the total 
number of transcripts is at least an 
order of magnitude larger than cur-
rent estimates of genes present in 
the mouse genome. Furthermore, 
only about 40% of characterized 
ncRNA sequences were identified 
in previous FANTOM cDNA collec-
tions, suggesting that the number 
of unannotated transcripts could 
continue to grow. Sequencing of 3 
million human CAGE tags also con-
firmed that human cells have a simi-
lar level of transcriptional diversity. 
Analysis of human gene expression 
by MPSS found that >65% of signa-
ture sequences do not overlap with 
annotated transcripts; rather, 38% 
map to introns, 21% are antisense 
to known exons, and 5% map to 
intergenic areas. Intergenic tran-
scripts are expressed at low levels 
on arrays, and it may be that the 
cloning and sequencing methodolo-
gies of MPSS require greater analy-
sis to detect transcripts with such 
low abundance.
Antisense transcription is also 
observed in cDNA sequencing, 
corroborating findings in microar-evier Inc.ray studies. Transcription from the 
opposite strand of a protein-encod-
ing locus produces RNAs that may 
hybridize with DNA or RNA and could 
interfere with transcription, transla-
tion, or mRNA stability of the “sense” 
product. Systematic cDNA cloning of 
small RNAs from C. elegans identi-
fied 700 distinct endogenous siR-
NAs, possibly processed from larger 
antisense transcripts, precisely 
complementary to protein-coding 
regions from more than 500 differ-
ent genes; such small RNAs may 
act as siRNAs in plants (reviewed 
in Sontheimer and Carthew, 2005). 
Genomewide surveys of expressed 
mouse and human sequences and 
cDNA sequencing experiments iden-
tified a surprisingly large number of 
transcripts antisense to protein-cod-
ing genes. This suggests that the 
majority of sense transcripts (e.g., 
72% of mouse genes) may have an 
antisense partner (Katayama et al., 
2005).
Noncoding RNAs and Their 
Functions
A key question hangs like an ominous 
cloud over these observations of 
widespread transcription: are these 
transcripts biologically functional, 
or are they the transcriptional noise 
of a less than precise set of biologi-
cal processes? Recent experiments 
in mice in which megabase “gene 
desert” regions have been deleted 
underscore the relevance of this 
question. Deletion of 1.5 Mb and 0.8 
Mb genomic intervals, which together 
contain 1243 noncoding sequences 
conserved between rodent and pri-
mate, resulted in viable mice with 
no obvious deleterious phenotypes 
(Nobrega et al., 2004). However, if 
history is our guide, then the answer 
to this question may be complex (see 
Figure 1).
It has taken more than 35 years to 
identify and characterize seven func-
tional classes of ncRNAs: ribosomal 
(r), transfer (t), small nuclear (sn), 
antisense (AS), small nucleolar (sno), 
micro (mi) and Piwi-interacting (pi). 
With the exception of perhaps the 
rRNA and tRNA functional classes, the 
other ncRNA classes are believed to 
Figure 1. Discovery Timeline of Noncoding RNAs
This timeline highlights the discoveries of the different functional classes of noncoding RNAs 
(ncRNAs) and the emergence of evidence for widespread transcription throughout the genome. 
Widespread transcription produces of a plethora of unannotated RNA species, most of which 
are characterized by reduced protein coding potential. Examples of the many regulatory roles of 
ncRNAs in cellular processes are provided. Diversity in the size and function of ncRNAs coupled 
with the abundance of noncoding transcription suggest that many ncRNAs still await discovery. 
(See Table S1 for full citations for timeline events).be incomplete. Many other functions 
for noncoding transcripts have been 
identified, including transcriptional 
activation, gene silencing, imprint-
ing, dosage compensation, transla-
tional silencing, modulation of protein 
function, and binding as riboswitches 
to regulatory metabolites (reviewed 
in Kiss, 2002; Mattick and Makunin, 
2006; Zamore and Haley, 2005).One of the best characterized 
emerging classes of ncRNAs are the 
microRNAs (miRNAs) cloned over a 
decade ago in C. elegans and now 
recognized as a large conserved 
family of ?22-nucleotide regulatory 
RNAs essential for a variety of cellu-
lar processes (reviewed in Esquela-
Kerscher and Slack, 2006; Zamore 
and Haley, 2005). The differential Cell 125,expression patterns of miRNAs 
determine cell fate and correct dif-
ferentiation during development 
(for example, through regulation 
of Notch signaling and Hox gene 
expression). MicroRNAs can act 
as tumor suppressors and onco-
genes (for example, by regulating 
Bcl2, Ras, Myc, and E2F), and they 
can regulate cellular proliferation 
and apoptosis. Surprisingly, miRNA 
expression profiles appear to reflect 
more accurately the developmen-
tal lineage and differentiation state 
of tumors than do mRNA profiles. 
Hundreds of miRNAs are estimated 
to be present in the human genome, 
and computational analysis sug-
gests that more than 20%–30% 
of human genes are regulated by 
miRNAs. Microarray experiments 
support this view, revealing miRNA-
mediated downregulation of large 
numbers of target mRNAs. In addi-
tion, miRNAs suppress initiation of 
protein translation, promote mRNA 
degradation and turnover, and initi-
ate transcriptional silencing. How-
ever, the function of the vast major-
ity of miRNAs is as yet unknown.
Small nucleolar RNAs (snoRNAs), 
another abundant group of RNAs, 
reveal an ever-increasing retinue 
of cellular functions for ncRNAs 
(reviewed in Kiss, 2002). Originally 
appreciated for their processing 
of rRNAs and involvement in the 
posttranscriptional 2′-O-methyla-
tion and pseudouridylation of tar-
get rRNAs and snRNAs, the identi-
fication of many “orphan” snoRNAs 
lacking complementarity to rRNAs, 
snRNAs, and tRNAs suggests a 
broad range of RNA substrates 
for snoRNAs. Furthermore, snoR-
NAs are known to accumulate (and 
potentially function) outside of the 
nucleolus. Given that most snoR-
NAs are processed from the introns 
of other genes, their expression is 
inextricably linked to transcription 
of their host gene. For example, 
a brain-specific snoRNA called 
HBII-52 modulates alternate splic-
ing of the transcript encoding the 
serotonin receptor. Patients with 
Prader-Willi syndrome who lack 
HBII-52 have different serotonin  June 30, 2006 ©2006 Elsevier Inc. 1217
receptor splice forms, resulting in 
an alteration in serotonin efficacy 
(Kishore and Stamm, 2006).
The interaction of ncRNAs with pro-
teins is another way in which ncRNAs 
can exert their effects in the cell. 
For example, steroid receptor RNA 
activator (SRA) is a transcriptional 
coactivator whose action requires 
chromatin remodeling and recruit-
ment of histone deacetylases (Zhao 
et al., 2004). SRA facilitates estab-
lishment of the transcriptional pre-
initiation complex by interacting with 
nuclear receptors, probably forming 
a scaffold for the binding of coactiva-
tors (such as the DEAD box protein 
p72/p68) and corepressors (such as 
SHARP). A screen for evolutionarily 
conserved functional ncRNAs iden-
tified a noncoding repressor of the 
NFAT transcription factor (NRON) 
(Willingham et al., 2005). The dem-
onstrated interaction of NRON with 
nuclear import factors immediately 
suggests that NRON in a complex 
with importin-β specifically down-
regulates the nuclear import of NFAT, 
a hypothesis supported by stud-
ies of NFAT translocation. Indeed, 
given the complicated networks of 
nuclear-cytoplasmic transport and 
the seemingly limited number of 
available importin-β family members, 
such ncRNA-mediated regulation of 
specific cargo proteins may emerge 
as a common biological strategy 
for dealing with the complexity of 
intracellular trafficking. Activation of 
the heat shock transcription factor 
(HSF1) is mediated by an RNP com-
plex, which includes the translation 
elongation factor eEF1A and a new 
ncRNA called HSR1 (Shamovsky et 
al., 2006). Conserved from rodents 
to humans, HSR1 is essential for 
heat shock response activation and 
may act as an RNA thermosensor.
The identification of a specific 
class of small RNAs with a potential 
role in development has very recently 
been described. The Argonaute Piwi 
subfamily proteins have been shown 
to be important in germline develop-
ment (Cox et al., 1998). Girard et al. 
(2006) and Aravin et al. (2006) have 
now identified and characterized a 
highly abundant class of small RNAs 1218 Cell 125, June 30, 2006 ©2006 Elcalled piRNAs and showed them to 
be associated with the Piwi proteins 
MIWI (Girard et al., 2006) and MILI 
(Aravin et al., 2006) in murine testis. 
The slightly longer lengths (26–31 
nucleotides) and testes-specific 
expression of these piRNAs perhaps 
hint at the start of a growing num-
ber of developmental stage-specific 
or tissue-specific members of new 
classes of small RNAs.
Finally, the burgeoning number 
of putative ncRNA genes has been 
cited as a mechanism for increasing 
the complexity of gene regulatory 
networks and, together with alter-
native gene splicing, significantly 
increases the variety and complex-
ity of the transcriptome. The finding 
that the rising ratio of noncoding to 
protein-coding DNA correlates with 
increasing organismal complexity 
supports this notion (Mattick and 
Makunin, 2006). With the limited 
number of currently characterized 
ncRNAs acting in so many cellular 
processes and the demonstrated 
amount of unannotated transcription 
present in the genome, one can eas-
ily appreciate that ncRNAs probably 
function in more cellular pathways 
than their protein-coding brethren.
Implications of Noncoding 
Transcription
Noncoding RNAs possess several 
properties that make them attractive 
as regulatory factors. For example, 
miRNAs are 1000-fold smaller than 
most mRNAs. With their 20 nucleo-
tides, miRNAs can perform the task 
of a protein domain composed of 
100 amino acids. Considering the 
effects of compensatory base pair 
changes on structure and target 
hybridization, such RNAs could 
evolve much more readily than pro-
tein domains. The strong innate 
affinity of RNA for both DNA and 
RNA permits a diversity of stable 
mismatch-based secondary struc-
ture motifs such as stems, bulges, 
and loops. These elements may be 
stronger determinants of an RNA’s 
function than the primary sequence 
itself, and would help to explain the 
lack of evolutionary conservation 
observed among many ncRNAs. sevier Inc.Evolutionary conservation of even 
well-characterized and biologically 
important ncRNAs appears to be 
inconsistent at best. The let7 miRNA 
is conserved from worms to humans 
(Zamore and Haley, 2005), yet the 
dosage compensation ncRNA XIST 
appears to be rapidly evolving even 
among rodents (Nesterova et al., 
2001). Furthermore, of the ?34,000 
putative ncRNAs identified in 
mouse, only 3%–4% or so have lim-
ited human sequence conservation 
(Carninci et al., 2005). Only about 
7%–20% (depending on the study) 
of human unannotated transcripts 
appear to be conserved over most 
of their lengths with their mouse 
counterparts; thus, the majority are 
species-specific (Johnson et al., 
2005). Perhaps the criteria used 
to determine evolutionary conser-
vation should be reevaluated. For 
example, it could be that the lengths 
of the conserved sequences are 
short and discontinuous, resem-
bling islands of conservation within 
a larger nonconserved sequence. If 
such patches of conservation turn 
out to be biologically important for 
unannotated ncRNAs (as they are 
for miRNAs), the number of such 
conserved regions in the genome 
would escalate considerably.
Given the tolerance of RNA for 
mismatches and its probable reli-
ance on secondary structure for 
bioactivity, ncRNAs are likely to 
have a greater degree of plasticity 
than mRNAs. Often multiple miR-
NAs must be deleted to obtain a 
phenotype (Abbott et al., 2005)—an 
illustration of functional redundancy 
and regulatory complexity that may 
extend to other ncRNAs. Noncod-
ing RNAs have been implicated in 
a number of diseases, including B 
cell neoplasia, lung cancer, autism, 
DiGeorge syndrome, prostate can-
cer, and schizophrenia (see RNAdb, 
ht tp : // research. imb.uq.edu.au /
rnadb/). Considering the abundance 
of empirically observed ncRNAs, it is 
highly likely that many more will be 
linked to human diseases. In addi-
tion, miRNAs linked to cancer may 
prove valuable therapeutic targets 
(Esquela-Kerscher and Slack, 2006).
There are several strategies for 
investigating the function of new 
noncoding transcripts. Starting with 
a large number of putative mouse 
ncRNAs identified by the FANTOM 
project, Ravasi et al. used expres-
sion analysis tools such as micro-
arrays, PCR, and Northern blots 
combined with lipopolysaccharide 
treatment to validate the regulated 
expression of a subset of these 
ncRNAs (Ravasi et al., 2006). In a 
separate study but starting with the 
same set of mouse ncRNAs, Schultz 
and colleagues identified a subset 
of 512 ncRNAs apparently con-
served during human evolution; they 
then used siRNAs to disrupt these 
conserved ncRNAs and screened 
for phenotypes using a panel of 
cellular assays (Willingham et al., 
2005). Such detailed expression 
analyses and siRNA-mediated phe-
notypic screenings highlight a path 
for the followup characterization of 
newly mapped transcriptional “dark 
matter.” Disruption of an essential 
RNA processing pathway such as 
Dicer cleavage or rRNA maturation 
should have dramatic transcrip-
tional repercussions, which could 
be detected with tiling arrays. Such 
an experiment was conducted in 
yeast by depleting Rpp1, an essen-
tial protein required for both RNase 
P-mediated maturation of tRNAs 
and RNase MRP, which processes 
rRNA. This study revealed 74 new 
ncRNAs, many of which were anti-
sense to known protein coding 
genes (Samanta et al., 2006). Future 
efforts could focus on: (1) combined 
use of RNase footprinting and tiling 
arrays for genomewide identification 
of “protected” RNAs; (2) purification 
of RNA-associated proteins such as 
helicases and identification of their 
associated RNAs by tiling array; 
(3) classification of subcellular and 
structural fractionations of RNAs 
using tiling arrays; and (4) develop-
ment of higher-density tiling arrays 
that allow high-resolution genome-
wide surveys of transcription, per-
mitting investigation of rare tissues, 
primary cells derived from tissues, 
developmental time-courses, and 
other low abundance samples.How much of the nonredundant 
genome is transcribed? Based on 
published data, estimates range from 
10% to 60%. However, this may be an 
underestimate given the limited num-
ber of cells and differentiation states 
surveyed thus far. Furthermore, array-
based transcript mapping relies on 
conservative thresholds which select 
for the highest 2%–5% of probes, 
yielding a low false positive rate of a 
few percent. Given the low expression 
levels of many TUFs, these thresh-
olds are likely to be underestimates 
of the true amount of unannotated 
transcription. Indeed, unpublished 
data from our lab suggest that 75% 
of RACE products selected from ran-
dom regions of the human genome 
and hybridized to microarrays reveal 
the presence of complex transcripts. 
Analyzing the distribution of trans-
posable elements that are coun-
ter-selected when they occur within 
functional transcriptional units (FTUs) 
implies that >50% of the genome 
consists of FTUs, and one-third of 
these are likely to be ncRNAs (Semon 
and Duret, 2004). Weighing these 
factors together, we suggest that 
all of the non-repeat portions of the 
human genome are transcribed. This 
may seem an excessive estimate, yet 
recent data in yeast imply that more 
that 85% of its genome is transcribed 
(David et al., 2006). Furthermore, 
large-scale cDNA sequencing and 
annotation in the mouse has shown 
that 62% of the mouse genome is 
transcribed (Carninci et al., 2005), 
and there are estimates that 90% of 
the human genome is transcribed 
(Wong et al., 2001). The overall archi-
tecture of transcribed portions of the 
genome is highly complex. Indeed, 
the landscape of most transcriptomes 
is a lattice-like network of overlap-
ping transcription in which the same 
genomic sequences often serve as 
portions of separately regulated tran-
scripts, making the boundaries and 
indeed the concept of the term gene 
less useful than it once was.
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